Locally Advanced Or Metastatic Her2 Expressing Cancers clinical trials

Explore recruiting locally advanced or metastatic her2 expressing cancers clinical trials.

Recruiting locally advanced or metastatic her2 expressing cancers studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Locally Advanced Or Metastatic Her2 Expressing Cancers trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1 First-in-Human Study of the Safety and Effects of VIR-5818 Alone or with Pembrolizumab in Participants with Advanced or Metastatic HER2-Expressing Cancers

Spain, France, Portugal

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Locally Advanced Or Metastatic Her2 Expressing Cancers trials by city

Locally Advanced Or Metastatic Her2 Expressing Cancers in Toronto Locally Advanced Or Metastatic Her2 Expressing Cancers in Vancouver Locally Advanced Or Metastatic Her2 Expressing Cancers in Montreal Locally Advanced Or Metastatic Her2 Expressing Cancers in Calgary Locally Advanced Or Metastatic Her2 Expressing Cancers in Edmonton Locally Advanced Or Metastatic Her2 Expressing Cancers in Ottawa Locally Advanced Or Metastatic Her2 Expressing Cancers in Winnipeg Locally Advanced Or Metastatic Her2 Expressing Cancers in Quebec City Locally Advanced Or Metastatic Her2 Expressing Cancers in Hamilton Locally Advanced Or Metastatic Her2 Expressing Cancers in Kitchener Locally Advanced Or Metastatic Her2 Expressing Cancers in London Locally Advanced Or Metastatic Her2 Expressing Cancers in Halifax Locally Advanced Or Metastatic Her2 Expressing Cancers in New York Locally Advanced Or Metastatic Her2 Expressing Cancers in Los Angeles Locally Advanced Or Metastatic Her2 Expressing Cancers in Chicago Locally Advanced Or Metastatic Her2 Expressing Cancers in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease